Le Pen Lab
My research seeks to explain a fundamental paradox in human disease: why common viral infections cause little harm in most individuals yet lead to life-threatening or chronic disease in others. We investigate the cell-intrinsic mechanisms of innate immunity that enable cells to detect viruses, limit infection, and resolve immune activation after the pathogen has been cleared. Our work has revealed that these fundamental pathways can determine the outcome of infection, shaping both antiviral defense and inflammatory pathology.
Location
651 Huntington Avenue,
Building FXB, Room 205
Boston, MA 02115
Publications
Featured Publications
- A genome-wide arrayed CRISPR screen identifies PLSCR1 as an intrinsic barrier to SARS-CoV-2 entry that recent virus variants have evolved to resist
- The antiviral state of the cell: lessons from SARS-CoV-2
- Inborn errors of OAS–RNase L in SARS-CoV-2–related multisystem inflammatory syndrome in children
- Inborn errors of type I IFN immunity in patients with life-threatening COVID-19
- Terminal uridylyltransferases target RNA viruses as part of the innate immune system
- A deletion polymorphism in the Caenorhabditis elegans RIG-I homolog disables viral RNA dicing and antiviral immunity